Log In
BCIQ
Print this Print this
 

methylphenidate (NWP09)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionMethylphenidate extended-release chewable tablets
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat attention deficit hyperactivity disorder (ADHD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today